Abstract
To enhance glioblastoma (GB) marker discovery, we compared gene expression in GB with human normal brain (NB) by accessing the SAGE Genie web site and compared the results with published data. Nine GB and five NB SAGE libraries were analyzed using the Digital Gene Expression Displayer (DGED); the results of DGED were tested by Northern blot analysis and RT-PCR of arbitrarily selected genes. Review of available data from the articles on gene expression profiling by microarray-based hybridization showed as few as 35 overlapped genes with increased expression in GB. Some of them were identified in four articles, but most genes were identified in three or even in two investigations. Some differences were also found between SAGE results of GB analysis. The Digital Gene Expression Displayer approach revealed 676 genes differentially expressed in GB vs. NB with cutoff ratio: twofold change and P ≤ 05. Differential expression of selected genes obtained by DGED was confirmed by Northern analysis and RT-PCR. Altogether, only 105 of 955 genes presented in published investigations were among the genes obtained by DGED. Comparison of the results obtained by microarrays and SAGE is very complicated because the authors present only the most prominent differentially expressed genes. However, even available data give quite poor overlapping of genes revealed by microarrays. Some differences between results obtained by SAGE in different investigations can be explained by high dependence on the statistical methods used. As for now, the best solution to search for molecular tumor markers is to compare all available results and to select only those genes where significant expression in tumors combined with very low expression in normal tissues was reproduced in several articles. One hundred five differentially expressed genes, common to both methods, can be included in the list of candidates for the molecular typing of GBs. Some genes, encoded cell surface or extracellular proteins may be useful for targeting gliomas with antibody-based therapy.
Similar content being viewed by others
References
Schena, M., Shalon, D., Davis, R.W., and Brown, P.O., Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray, Science, 1995, vol. 270, pp. 467–470.
Lockhart, D.J., Dong, H., Byrne, M.C., Follettie, M.T., Gallo, M.V., Chee, M.S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H., and Brown, E.L., Expression Monitoring by Hybridization to High-Density Oligonucleotide Arrays, Nat. Biotech., 1996, vol. 14, pp. 1675–1680.
Lipshutz, R.J., Fodor, S.P., Gingeras, T.R., and Lockhart, D.J., High Density Synthetic Oligonucleotide Arrays, Nat. Genet., 1999, vol. 21, issue 1, pp. 20–24.
Velculescu, V.E., Zhang, L., Vogelstein, B., and Kinzler, K.W., Serial Analysis of Gene Expression, Science, 1995, vol. 270, pp. 484–487.
Lash, A.E., Tolstoshev, C.M., Wagner, L., Schuler, G.D., Strausberg, R.L., Riggins, G.J., and Altschul, S.F., SAGEmap: a Public Gene Expression Resource, Genome Res., 2000, vol. 10, pp. 1051–1060.
Saha, S., Sparks, A.B., Rago, C., Akmaev, V., Wang, C.J., Vogelstein, B., Kinzler, K.W., and Velculescu, V.E., Using the Transcriptome to Annotate the Genome, Nat. Biotechnol., 2002, vol. 20, pp. 508–512.
Shostak, K., Labunskyy, V., Dmitrenko, V., Malisheva, T., Shamayev, M., Rozumenko, V., Zozulya, Y., Zehetner, G., and Kavsan, V., HC gp-39 Gene is Upregulated in Glioblastomas, Cancer Lett., 2003, vol. 198, pp. 203–210.
Kavsan, V., Shostak, K., Dmitrenko, V., Chausovskiy, T., Zozulya, Y., and Demotes-Mainard, J., Peculiarities of Molecular Events in Human Glial Tumors Revealed by Serial Analysis of Gene Expression (SAGE), Exp. Oncol., 2004, vol. 26, pp. 196–204.
Dmitrenko, V., Shostak, K., Boyko, O., Khomenko, O., Rozumenko, V., Malisheva, T., Shamayev, M., Zozulya, Y., and Kavsan, V., Reduction of the Transcription Level of the Mitochondrial Genome in Human Glioblastoma, Cancer Lett., 2005, vol. 218, pp. 99–107.
Rae, F.K., Stephenson, S.A., Nicol, D.L., and Clements, J.A., Novel Association of a Diverse Range of Genes with Renal Cell Carcinoma as Identified by Differential Display, Int. J. Cancer., 2000, vol. 88, pp. 726–732.
Fuller, G.N., Rhee, C.H., Hess, K.R., Caskey, L.S., Wang, R., Bruner, J.M., Yung, W.K., and Zhang, W., Reactivation of Insulin-Like Growth Factor Binding Protein 2 Expression in Glioblastoma Multiforme: A Revelation by Parallel Gene Expression Profiling, Cancer Res., 1999, vol. 59, pp. 4228–4232.
Sallinen, S.L., Sallinen, P.K., Haapasalo, H.K., Helin, H.J., Helen, P.T., Schraml, P., Kallioniemi, O.P., and Kononen, J., Identification of Differentially Expressed Genes in Human Gliomas by DNA Microarray and Tissue Chip Techniques, Cancer Res., 2000, vol. 60, pp. 6617–6622.
Kim, S., Dougherty, E.R., Shmulevich, I., Hess, K.R., Hamilton, S.R., Trent, J.M., Fuller, G.N., and Zhang, W., Identification of Combination Gene Sets for Glioma Classification, Mol. Cancer Ther., 2002, vol. 1, pp. 1229–1236.
Raza, S.M., Fuller, G.N., Rhee, C.H., Huang, S., Hess, K., Zhang, W., and Sawaya, R., Identification of Necrosis-Associated Genes in Glioblastoma by cDNA Microarray Analysis, Clin. Cancer Res., 2004, vol. 10,part 1, pp. 212–221.
Godard, S., Getz, G., Delorenzi, M., Farmer, P., Kobayashi, H., Desbaillets, I., Nozaki, M., Diserens, A.C., Hamou, M.F., Dietrich, P.Y., Regli, L., Janzer, R.C., Bucher, P., Stupp, R., De Tribolet, N., Domany, E., and Hegi, M.E., Classification of Human Astrocytic Gliomas on the Basis of Gene Expression: a Correlated Group of Genes with Angiogenic Activity Emerges as a Strong Predictor of Subtypes, Cancer Res., 2003, vol. 63, pp. 6613–6625.
Somasundaram, K., Reddy, S.P., Vinnakota, K., Britto, R., Subbarayan, M., Nambiar, S., Hebbar, A., Samuel, C., Shetty, M., Sreepathi, H.K., Santosh, V., Hegde, A.S., Hegde, S., Kondaiah, P., and Rao, M.R., Upregulation of ASCL1 and Inhibition of Notch Signaling Pathway Characterize Progressive Astrocytoma, Oncogene, 2005, vol. 24, pp. 7073–7083.
Rickman, D.S., Bobek, M.P., Misek, D.E., Kuick, R., Blaivas, M., Kurnit, D.M., Taylor, J., and Hanash, S.M., Distinctive Molecular Profiles of High-Grade and Low-Grade Gliomas Based on Oligonucleotide Microarray Analysis, Cancer Res., 2001, vol. 61, pp. 6885–6891.
Markert, J.M., Fuller, C.M., Gillespie, G.Y., Bubien, J.K., McLean, L.A., Hong, R.L., Lee, K., Gullans, S.R., Mapstone, T.B., and Benos, D.J., Differential gene expression Profiling in Human Brain Tumors, Phys. Genom., 2001, vol. 5, pp. 21–33.
van den Boom, J., Wolter, M., Kuick, R., Misek, D.E., Youkilis, A.S., Wechsler, D.S., Sommer, C., Reifenberger, G., and Hanash, S.M., Characterization of Gene Expression Profiles Associated with Glioma Progression Using Oligonucleotide-Based Microarray Analysis and Real-Time Reverse Transcription-Polymerase Chain Reaction, Amer. J. Pathol., 2003, vol. 163, pp. 1033–1043.
Ljubimova, J.Y., Lakhter, A.J., Loksh, A., Yong, W.H., Riedinger, M.S., Miner, J.H., Sorokin, L.M., Ljubimov, A.V., and Black, K.L., Overexpression of alpha4 Chain-Containing Laminins in Human Glial Tumors Identified by Gene Microarray Analysis, Cancer Res., 2001, vol. 61, pp. 5601–5610.
Tanwar, M.K., Gilbert, M.R., and Holland, E.G., Gene Expression Microarray Analysis Reveals YKL-40 to Be a Potential Serum Marker for Malignant Character in Human Glioma, Cancer Res., 2002, vol. 62, pp. 4364–4368.
Mischel, P.S., Shai, R., Shi, T., Horvath, S., Lu, K.V., Choe, G., Seligson, D., Kremen, T.J., Palotie, A., Liau, L.M., Cloughesy, T.F., and Nelson, S.F., Identification of Molecular Subtypes of Glioblastoma by Gene Expression Profiling, Oncogene, 2003, vol. 22, pp. 2361–2373.
Nutt, C.L., Mani, D.R., Betensky, R.A., Tamayo, P., Cairncross, J.G., Ladd, C., Pohl, U., Hartmann, C., McLaughlin, M.E., Batchelor, T.T., Black, P.M., von Deimling, A., Pomeroy, S.L., Golub, T.R., and Louis, D.N., Gene Expression-Based Classification of Malignant Gliomas Correlates Better with Survival Than Histological Classification, Cancer Res., 2003, vol. 63, pp. 1602–1607.
Nigro, J.M., Misra, A., Zhang, L., Smirnov, I., Colman, H., Griffin, C., Ozburn, N., Chen, M., Pan, E., Koul, D., Yung, W.K., Feuerstein, B.G., and Aldape, K.D., Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma, Cancer Res., 2005, vol. 65, pp. 1678–1686.
Freije, W.A., Castro-Vargas, F.E., Fang, Z., Horvath, S., Cloughesy, T., Liau, L.M., Mischel, P.S., and Nelson, S.F., Gene Expression Profiling of Gliomas Strongly Predicts Survival, Cancer Res., 2004, vol. 64, pp. 6503–6510.
Yokota, T., Kouno, J., Adachi, K., Takahashi, H., Teramoto, A., Matsumoto, K., Sugisaki, Y., Onda, M., and Tsunoda, T., Identification of Histological Markers for Malignant Glioma by Genome-Wide Expression Analysis: Dynein, alpha-PIX and Sorcin, Acta Neuropathol., 2006, vol. 111, pp. 29–38.
Liau, L.M., Lallone, R.L., Seitz, R.S., Buznikov, A., Gregg, J.P., Kornblum, H.I., Nelson, S.F., and Bronstein, J.M., Identification of a Human Glioma-Associated Growth Factor Gene, Granulin, Using Differential Immuno-Absorption, Cancer Res., 2000, vol. 60, pp. 1353–1360.
Bammler, T., Beyer, R.P., Bhattacharya, S., Boorman, G.A., Boyles, A., Bradford, B.U., Bumgarner, R.E., Bushel, P.R., Chaturvedi, K., Choi, D., Cunningham, M.L., Deng, S., Dressman, H.K., Fannin, R.D., Farin, F.M., Freedman, J.H., Fry, R.C., Harper, A., Humble, M.C., Hurban, P., Kavanagh, T.J., Kaufmann, W.K., Kerr, K.F., Jing, L., Lapidus, J.A., Lasarev, M.R., Li, J., Li, Y.J., Lobenhofer, E.K., Lu, X., Malek, R.L., Milton, S., Nagalla, S.R., O’malley, J.P., Palmer, V.S., Pattee, P., Paules, R.S., Perou, C.M., Phillips, K., Qin, L.X., Qiu, Y., Quigley, S.D., Rodland, M., Rusyn, I., Samson, L.D., Schwartz, D.A., Shi, Y., Shin, J.L., Sieber, S.O., Slifer, S., Speer, M.C., Spencer, P.S., Sproles, D.I., Swenberg, J.A., Suk, W.A., Sullivan, R.C., Tian, R., Tennant, R.W., Todd, S.A., Tucker, C.J., Van Houten, B., Weis, B.K., Xuan, S., and Zarbl, H., Members of the Toxicogenomics Research Consortium. Standardizing Global gene Expression Analysis between Laboratories and Across Platforms, Nat. Methods, 2005, vol. 2, pp. 351–356.
Irizarry, R.A., Warren, D., Spencer, E., Kim, I.F., Biswal, S., Frank, B.C., Gabrielson, E., Garcia, J.G., Geoghegan, J., Germino, G., Griffin, C., Hilmer, S.C., Hoffman, E., Jedlicka, A.E., Kawasaki, E., Martinez-Murillo, E., Morsberger, L., Lee, H., Petersen, D., Quackenbush, J., Scott, A., Wilson, M., Yang, Y., Ye, S.Q., and Yu.W., Multiple-Laboratory Comparison of Microarray Platforms, Nat. Methods, 2005, vol. 2, pp. 345–350.
Larkin, J.E., Frank, B.C., Gavras, H., Sultana, R., and Quackenbush, J., Independence and Reproducibility Across Microarray Platforms, Nat. Methods, 2005, vol. 2, pp. 337–344.
Petersen, D., Chandramouli, G.V.R., Geoghegan, J., Hilburn, J., Paarlberg, J., Kim, C.H., Munroe, D., Gangi, L., Han, J., Puri, R., Staudt, L., Weinstein, J., Barrett, J.C., Green, J., and Kawasaki, E.S., Three Microarray Platforms: An Analysis of Their Concordance in Profiling Gene Expression, BMC Genomics, 2005, vol. 6, p. 63.
Harris, L., Data Stands up to scrutiny, The Scientist., 2005, vol. 18, pp. 32–40.
Boon, K., Osorio, E.G., Greenhut, S.F., Schaefer, C.F., Shoemaker, J., Polyak, K., Morin, P.J., Buetow, K.H., Strausberg, R.L., De Souza, S.J., and Riggins, G.J., An Anatomy of Normal and Malignant Gene Expression, Proc. Nat. Acad. Sci. USA, 2002, vol. 99, pp. 11287–11292.
Lal, A., Lash, A.E., Altschul, S.F., Velculescu, V., Zhang, L., McLendon, R.E., Marra, M.A., Prange, C., Morin, P.J., Polyak, K., Papadopoulos, N., Vogelstein, B., Kinzler, K.W., Strausberg, R.L., and Riggins, G.J., A Public Database for Gene Expression in Human Cancers, Cancer Res., 1999, vol. 59, pp. 5403–5407.
Loging, W.T., Lal, A., Siu, I.M., Loney, T.L., Wikstrand, C.J., Marra, M.A., Prange, C., Bigner, D.D., Strausberg, R.L., and Riggins, G.J., Identifying Potential Tumor Markers and Antigens by Database Mining and Rapid Expression Screening, Genome Res., 2000, vol. 10, pp. 1393–1402.
Boon, K., Edwards, J.B., Eberhart, C.D., and Riggins, G.J., Identification of Astrocytoma Associated Genes Including Cell Surface Markers, BMC Cancer., 2004, vol. 4, p. 39.
Madden, S.L., Cook, B.P., Nacht, M., Weber, W.D., Callahan, M.R., Jiang, Y., Dufault, M.R., Zhang, X., Zhang, W., Walter-Yohrling, J., Rouleau, C., Akmaev, V.R., Wang, C.J., Cao, X., St Martin, T.B., Roberts, B.L., Teicher, B.A., Klinger, K.W., Stan, R.V., Lucey, B., Carson-Walter, E.B., Laterra, J., and Walter, K.A., Vascular Gene Expression in Nonneoplastic and Malignant Brain, Am. J. Pathol., 2004, vol. 165, pp. 601–608.
Cerutti, J.M., Riggins, G.J., and de Souza, S.J., What Can Digital Transcript Profiling Reveal about Human Cancers?, Braz. J. Med. Biol. Res., 2003, vol. 36, 975–985.
Hakala, B.E., White, C., and Recklies, A.D., Human Cartilage gp-39, a Major Secretory Product of Articular Chondrocytes and Synovial Cells, is a Mammalian Member of a Chitinase Protein Family, J. Biol. Chem., 1993, vol. 268, pp. 25 803–25 810.
Author information
Authors and Affiliations
Additional information
The text was submitted by the authors in English.
About this article
Cite this article
Kavsan, V.M., Dmitrenko, V.V., Shostak, K.O. et al. Comparison of microarray and SAGE techniques in gene expression analysis of human glioblastoma. Cytol. Genet. 41, 30–48 (2007). https://doi.org/10.3103/S0095452707010069
Received:
Issue Date:
DOI: https://doi.org/10.3103/S0095452707010069